These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

9494 related items for PubMed ID: 11007930

  • 1. Cytokine-based therapy for melanoma: pre-clinical studies.
    Shurin MR, Kirkwood JM, Esche C.
    Forum (Genova); 2000; 10(3):204-26. PubMed ID: 11007930
    [Abstract] [Full Text] [Related]

  • 2. A new mouse model of experimental melanoma for vaccine and lymphokine therapy.
    Shrayer DP, Bogaars H, Wolf SF, Hearing VJ, Wanebo HJ.
    Int J Oncol; 1998 Aug; 13(2):361-74. PubMed ID: 9664134
    [Abstract] [Full Text] [Related]

  • 3. Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
    Indrová M, Bubeník J, Mikysková R, Mendoza L, Símová J, Bieblová J, Jandlová T, Jinoch P, Smahel M, Vonka V, Pajtasz-Piasecka E.
    Int J Oncol; 2003 Mar; 22(3):691-5. PubMed ID: 12579325
    [Abstract] [Full Text] [Related]

  • 4. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
    Stagg J, Wu JH, Bouganim N, Galipeau J.
    Cancer Res; 2004 Dec 15; 64(24):8795-9. PubMed ID: 15604233
    [Abstract] [Full Text] [Related]

  • 5. Preliminary experiences of intralesional immunotherapy in cutaneous metastatic melanoma.
    Ridolfi L, Ridolfi R.
    Hepatogastroenterology; 2002 Dec 15; 49(44):335-9. PubMed ID: 11995445
    [Abstract] [Full Text] [Related]

  • 6. Enhanced adjuvant effect of granulocyte-macrophage colony-stimulating factor plus interleukin-12 compared with either alone in vaccine-induced tumor immunity.
    Aruga A, Tanigawa K, Aruga E, Yu H, Chang AE.
    Cancer Gene Ther; 1999 Dec 15; 6(1):89-95. PubMed ID: 10078968
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Induction of potent antitumor response by vaccination with tumor lysate-pulsed macrophages engineered to secrete macrophage colony-stimulating factor and interferon-gamma.
    Lei H, Ju DW, Yu Y, Tao Q, Chen G, Gu S, Hamada H, Cao X.
    Gene Ther; 2000 Apr 15; 7(8):707-13. PubMed ID: 10800095
    [Abstract] [Full Text] [Related]

  • 9. Ex vivo and in vivo adenovirus-mediated gene therapy strategies induce a systemic anti-tumor immune defence in the B16 melanoma model.
    Bonnekoh B, Greenhalgh DA, Chen SH, Block A, Rich SS, Krieg T, Woo SL, Roop DR.
    J Invest Dermatol; 1998 Jun 15; 110(6):867-71. PubMed ID: 9620291
    [Abstract] [Full Text] [Related]

  • 10. Gene gun-mediated oral mucosal transfer of interleukin 12 cDNA coupled with an irradiated melanoma vaccine in a hamster model: successful treatment of oral melanoma and distant skin lesion.
    Wang J, Murakami T, Hakamata Y, Ajiki T, Jinbu Y, Akasaka Y, Ohtsuki M, Nakagawa H, Kobayashi E.
    Cancer Gene Ther; 2001 Oct 15; 8(10):705-12. PubMed ID: 11687893
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.
    Soiffer R, Hodi FS, Haluska F, Jung K, Gillessen S, Singer S, Tanabe K, Duda R, Mentzer S, Jaklitsch M, Bueno R, Clift S, Hardy S, Neuberg D, Mulligan R, Webb I, Mihm M, Dranoff G.
    J Clin Oncol; 2003 Sep 01; 21(17):3343-50. PubMed ID: 12947071
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic efficacy of antigen-specific vaccination and toll-like receptor stimulation against established transplanted and autochthonous melanoma in mice.
    Tormo D, Ferrer A, Bosch P, Gaffal E, Basner-Tschakarjan E, Wenzel J, Tüting T.
    Cancer Res; 2006 May 15; 66(10):5427-35. PubMed ID: 16707471
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
    Palucka AK, Ueno H, Connolly J, Kerneis-Norvell F, Blanck JP, Johnston DA, Fay J, Banchereau J.
    J Immunother; 2006 May 15; 29(5):545-57. PubMed ID: 16971810
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 475.